Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Publication year range
1.
Inflammation ; 44(5): 1856-1864, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33855682

ABSTRACT

Asthma-induced pulmonary fibrosis (PF) is an important public health concern that has few treatment options given its poorly understood etiology; however, the epithelial to mesenchymal transition (EMT) of pulmonary epithelial cells has been implicated to play an important role in inducing PF. Although previous studies have found atractylon (Atr) to have anti-inflammatory effects, whether Atr has anti-PF abilities remains unknown. The purpose of the current study was to validate the protective efficiency of Atr in both an animal model of ovalbumin (OVA)-induced asthma and an EMT model induced by transforming growth factor-ß1 (TGF-ß1) using TC-1 cells. The results of this study revealed that Atr treatment suppressed OVA-induced PF via fibrosis-related protein expression. Atr treatment suppressed OVA-induced circRNA-0000981 and TGFBR2 expression but promoted miR-211-5p expression. In vivo studies revealed that Atr suppressed TGF-ß1-induced EMT and fibrosis-related protein expression via suppressing circRNA-0000981 and TGFBR2 expression. The results also suggested that the downregulation of circRNA-0000981 expression suppressed TGFBR2 by sponging miR-211-5p, which was validated by a luciferase reporter assay. Collectively, the findings of the present study suggest that Atr treatment attenuates PF by regulating the mmu_circ_0000981/miR-211-5p/TGFBR2 axis in an OVA-induced asthma mouse model.


Subject(s)
Asthma/drug therapy , MicroRNAs , Pulmonary Fibrosis/prevention & control , RNA, Circular/antagonists & inhibitors , Receptor, Transforming Growth Factor-beta Type II/antagonists & inhibitors , Sesquiterpenes/therapeutic use , Animals , Asthma/chemically induced , Asthma/metabolism , Cell Line , Male , Mice , Mice, Inbred BALB C , MicroRNAs/biosynthesis , Ovalbumin/toxicity , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/metabolism , RNA, Circular/biosynthesis , Receptor, Transforming Growth Factor-beta Type II/biosynthesis , Sesquiterpenes/pharmacology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL